ERBB2 and neoplasm: A recent GWAS identified several novel loci that were associated with at least one tumour feature (ER-status, progesterone receptor status, tumour grade, human epidermal growth factor 2 receptor) and also loci that differed by the molecular subtype, luminal or non-luminal, of breast cancer19.